CONMED Corp — Director's Dealing 2024

Jun 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-05-31

Reporting Person: Lande Jerome J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-31	Common Stock	M	302	—	Acquired	3856	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-31	Rsus (restricted Stock Units)	$0	M	302	Disposed	2033-06-01	Common Stock (302)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Indirect

Footnotes

F1: Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.